Striatal mechanism of the restless legs syndrome
Abstract Study Objectives Brain iron deficiency has been reported to be associated with the
restless legs syndrome (RLS). However, 30%–50% of RLS patients do not respond to iron …
restless legs syndrome (RLS). However, 30%–50% of RLS patients do not respond to iron …
Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?
Background: Several studies have reported the efficacy of intravenous (IV) iron for patients
with restless legs syndrome (RLS), but little is known about the efficacy or safety of repeated …
with restless legs syndrome (RLS), but little is known about the efficacy or safety of repeated …
[HTML][HTML] Current updates in Restless Legs Syndrome: A pragmatic review
A Makharia, A Agarwal, AK Srivastava… - Annals of Movement …, 2024 - journals.lww.com
Restless legs syndrome (RLS), also called Willis–Ekbom disease (WED), affects
approximately 3% of the global population, with higher incidence in Caucasians and …
approximately 3% of the global population, with higher incidence in Caucasians and …
Striatal mechanism of the restless legs syndrome
L Yuan-Yang, KC Hsieh, KT Chew, D Nguyen… - Sleep, 2022 - search.proquest.com
Study Objectives Brain iron deficiency has been reported to be associated with the restless
legs syndrome (RLS). However, 30%–50% of RLS patients do not respond to iron therapy …
legs syndrome (RLS). However, 30%–50% of RLS patients do not respond to iron therapy …
[HTML][HTML] Medical Case Report on Repeat Treatment of Restless Legs Syndrome with Intravenous Infusion of Iron
K Condon, J Chipman - Case Reports in Neurology, 2022 - karger.com
Restless legs syndrome (RLS) is a debilitating neurological disorder for which a range of
medical interventions with varied efficacy has been employed. Based on evidence of iron …
medical interventions with varied efficacy has been employed. Based on evidence of iron …
Neue Aspekte zur Eisentherapie des RLS in der Praxis–Teil 1
HK Goischke - psychopraxis. neuropraxis, 2021 - Springer
Die gegenwärtigen pathophysiologischen Erkenntnisse zum Fe-Mangel im Gehirn beim
RLS favorisieren eine Fe-Behandlung als „First-Line-Therapie “, als orale Fe-Gabe oder …
RLS favorisieren eine Fe-Behandlung als „First-Line-Therapie “, als orale Fe-Gabe oder …